Author： Paramore L.C.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.22, Iss.5, 2004-01, pp. : 275-284
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Impact of Respiratory Syncytial Virus: The Nurse's Perspective
Drugs in R&D, Vol. 11, Iss. 3, 2011-09 ,pp. :
Access to resources
Recommend
Respiratory Syncytial Virus Immunoprophylaxis: Impact on Epidemiology
By Dougherty N.N. Meissner H.C.
Pediatric Drugs, Vol. 2, Iss. 2, 2000-03 ,pp. :
Respiratory syncytial virus antiviral agents
By Prince G.A.
Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 6, 1999-06 ,pp. :
Development of respiratory syncytial virus vaccines
Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. :